1 year return (CAGR)
61.21%
Supernus Pharmaceuticals Inc Exchange (NASDAQ, USD)
SUPN
43.29
+0.83 (+1.61%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
11.93%
5 year return (CAGR)
11.42%
10 year return (CAGR)
11.78%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.01B
Price/Sales
4.19
Ent value
3.27B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
12.39
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 49.78 |
| Daily high | 52.50 |
| Daily low | 49.78 |
| Daily Volume | 1.05M |
| All-time high | 59.85 |
| 1y analyst estimate | 61.75 |
| Beta | 0.56 |
| EPS (TTM) | -1006.07 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SUPN | S&P500 | |
| Current price drop from All-time high | -27.67% | -1.38% |
| Highest price drop | -75.86% | -56.47% |
| Date of highest drop | 18 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -36.83% | -10.68% |
| Avg time to new high | 39 days | 12 days |
| Max time to new high | 1974 days | 1805 days |
News
